Replies to post #80703 on Ayala Pharmaceuticals Inc (ADXS)

[blueyedcatch]

Sorry but I can`t join insanity. There`s no proof that Axal is gonna be shelved,or that no ones interested in partnering. It`s more likely that the offers that were given for it were`nt satisfactory to Adxs,and would`nt come close to reinbursing them for taking the drug to this stage. Adxs would rather dilute then give away science,,because those platforms are money spent. If the results for Axal were bad,and the GOG did`nt say what they said about them,then it would be different,but it`s not,so don`t give up hope for Axal just yet,,it`s not over till the Ken boy says it is.

[Bourbon_on_my_cornflakes]

"Reality is they sold half the company this year for 65 million"

much less than that. They got $18.5 in the first offering, and the current one is a GROSS $20n, which means another $18.5

That's $37 million. IF the warrants convert that would be an extra $20m.

And people scoffed when I said they should sell the beech for $7 share.